Proteomic profiling of serum identifies a molecular signature that correlates with clinical outcomes in COPD.

Dagher, Rania; Fogel, Paul; Wang, Jingya; Soussan, David; Chiang, Chia-Chien; Kearley, Jennifer; Muthas, Daniel; Taillé, Camille; Berger, Patrick; Bourdin, Arnaud; Chenivesse, Cécile; Leroy, Sylvie; Anderson, Gary; Humbles, Alison A; Aubier, Michel; Kolbeck, Roland; Pretolani, Marina

Dagher, Rania; Fogel, Paul; Wang, Jingya; Soussan, David; Chiang, Chia-Chien; Kearley, Jennifer; Muthas, Daniel; Taillé, Camille; Berger, Patrick; Bourdin, Arnaud; Chenivesse, Cécile; Leroy, Sylvie; Anderson, Gary; Humbles, Alison A; Aubier, Michel; Kolbeck, Roland; Pretolani, Marina.

Afiliación

Dagher R; Bioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, United States of America.
Fogel P; Independent Consultant, Paris, France.
Wang J; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, United States of America.
Soussan D; Inserm UMR1152, Physiopathologie et Epidémiologie des Maladies Respiratoires, Université Paris Cité, Faculté de Médecine, Site Bichat, Paris, France.
Chiang CC; Laboratory of Excellence INFLAMEX, Université Paris-Cité, Paris, France.
Kearley J; Data Sciences and AI, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, United States of America.
Muthas D; Bioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, United States of America.
Taillé C; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Berger P; Inserm UMR1152, Physiopathologie et Epidémiologie des Maladies Respiratoires, Université Paris Cité, Faculté de Médecine, Site Bichat, Paris, France.
Bourdin A; Laboratory of Excellence INFLAMEX, Université Paris-Cité, Paris, France.
Chenivesse C; Service de Pneumologie A - Groupement Hospitalier Universitaire Nord Bichat-Claude Bernard, Paris, France.
Leroy S; Inserm UMR1045, Université de Bordeaux, Service d'explorations Fonctionnelles Respiratoires, Centre Hospitalo-Universitaire de Bordeaux, Bordeaux, France.
Anderson G; Inserm UMR1046, Université de Montpellier, Département de Pneumologie et Addictologie, Centre Hospitalo-Universitaire de Montpellier, Montpellier, France.
Humbles AA; Inserm UMR1158, Université Pierre et Marie Curie, Service de Pneumologie et Réanimation médicale, Centre Hospitalo-Universitaire La Pitié Salpêtrière, Paris, France.
Aubier M; Université de Nice and Service de Pneumologie Hôpital Pasteur, Centre Hospitalo-Universitaire de Nice, Nice, France.
Kolbeck R; Lung Health Research Centre, Department of Pharmacology and Therapeutics, University of Melbourne, Melbourne, Victoria, Australia.
Pretolani M; Bioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, United States of America.

PLoS One ; 17(12): e0277357, 2022.

Article en En | MEDLINE | ID: mdl-36480517

Asunto(s)

Proteómica; Enfermedad Pulmonar Obstructiva Crónica; Humanos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Proteómica Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google